ATE519782T1 - Peptide und ihre verwendung zur behandlung von hiv infektionen - Google Patents

Peptide und ihre verwendung zur behandlung von hiv infektionen

Info

Publication number
ATE519782T1
ATE519782T1 AT03813584T AT03813584T ATE519782T1 AT E519782 T1 ATE519782 T1 AT E519782T1 AT 03813584 T AT03813584 T AT 03813584T AT 03813584 T AT03813584 T AT 03813584T AT E519782 T1 ATE519782 T1 AT E519782T1
Authority
AT
Austria
Prior art keywords
amino acid
phenylalanine
cysteine
acid
alanine
Prior art date
Application number
AT03813584T
Other languages
English (en)
Inventor
Knut Adermann
Frank Kirchhoff
Jan Muench
Axel Schulz
Wolf-Georg Forssmann
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Application granted granted Critical
Publication of ATE519782T1 publication Critical patent/ATE519782T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
AT03813584T 2002-12-19 2003-12-19 Peptide und ihre verwendung zur behandlung von hiv infektionen ATE519782T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02028465 2002-12-19
PCT/EP2003/014654 WO2004056871A2 (en) 2002-12-19 2003-12-19 Peptides and their use for the treatment of hiv infections

Publications (1)

Publication Number Publication Date
ATE519782T1 true ATE519782T1 (de) 2011-08-15

Family

ID=32668727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03813584T ATE519782T1 (de) 2002-12-19 2003-12-19 Peptide und ihre verwendung zur behandlung von hiv infektionen

Country Status (8)

Country Link
US (1) US7655629B2 (de)
EP (1) EP1572743B1 (de)
JP (1) JP4505336B2 (de)
AT (1) ATE519782T1 (de)
AU (1) AU2003303218A1 (de)
CA (1) CA2509423A1 (de)
ES (1) ES2369771T3 (de)
WO (1) WO2004056871A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100144630A1 (en) * 1999-03-05 2010-06-10 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
US20100210528A1 (en) * 1999-03-05 2010-08-19 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
CA2569807A1 (en) * 2004-06-18 2005-12-29 Ipf Pharmaceuticals Gmbh Oligomeric peptides and their use for the treatment of hiv infections
EP1954302A4 (de) * 2005-11-02 2009-11-04 Ambrx Inc Biosynthetische polypeptid-fusionshemmer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0616614A1 (de) * 1991-04-18 1994-09-28 The Uab Research Foundation Zusammensetzungen und methoden zur inhibition von elastase
US5972901A (en) * 1994-03-23 1999-10-26 Case Western Reserve University Serpin enzyme complex receptor--mediated gene transfer
US6296164B1 (en) 1999-07-13 2001-10-02 Dale Medical Products, Inc. Medical device holder
EP1200616A2 (de) * 1999-07-29 2002-05-02 Case Western Reserve University Verbesserte verabreichung via serpinenzymkomplex rezeptor liganden
EP1959013B1 (de) * 1999-11-08 2014-04-23 IPF Pharmaceuticals GmbH Humanes zirkulierendes Virus inhibierendes Peptid (VIRIP) und seine Verwendung

Also Published As

Publication number Publication date
AU2003303218A1 (en) 2004-07-14
CA2509423A1 (en) 2004-07-08
WO2004056871A2 (en) 2004-07-08
EP1572743B1 (de) 2011-08-10
WO2004056871A3 (en) 2004-10-21
JP2006522584A (ja) 2006-10-05
US7655629B2 (en) 2010-02-02
ES2369771T3 (es) 2011-12-05
JP4505336B2 (ja) 2010-07-21
AU2003303218A8 (en) 2004-07-14
US20070072805A1 (en) 2007-03-29
EP1572743A2 (de) 2005-09-14

Similar Documents

Publication Publication Date Title
MXPA06014393A (es) Peptidos oligomericos y su uso para el tratamiento de infecciones por vih.
ATE368053T1 (de) Antimikrobielle peptide
DE69129226D1 (de) Glp-1-analoga verwendbar in der diabetesbehandlung
DK1531791T3 (da) Forebyggelse og begrænsning af iskæmi
WO2005123771B1 (en) Oligomeric peptides and their use for the treatment of hiv infections
FR2766191B1 (fr) Peptides anti-microbiens de crustaces
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
DE60228136D1 (de) Cytokin-proteinfamilie
ATE519782T1 (de) Peptide und ihre verwendung zur behandlung von hiv infektionen
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
DE69935414D1 (en) Humanes btrcp protein
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
ATE245168T1 (de) Peptide, die anti-zellanhaftungsaktivität aufweisen
ATE362769T1 (de) Lineare kationische peptide mit fungizider wirksamkeit
DE69117965D1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
SE9700301D0 (sv) New compound
EP0361956A3 (de) Expression von rekombinanten Proteinen mit niedrigem Molekulargewicht
WO2005094870A3 (en) Use of osteopontin fragment svvglr-derived peptides for the treatment of ischemic diseases
EA200401611A1 (ru) Пептиды gp41 и способы ингибирования слияния вич с клетками-мишенями на их основе
CY1115911T1 (el) Τροποποιημενα πολυπεπτιδια περιοχης kunitz και η χρηση τους στην μειωση της ισχαιμιας ή της εκκινησης μιας συστημικης φλεγμονωδους ανταποκρισης που σχετιζεται με μια χειρουργικη επεμβαση
ATE207496T1 (de) Neue peptide und nootroper wirkstoff
TH9693B (th) แอนตีบอดีแบบใหม่ สารออกฤทธิ์-เรนิน ที่ประกอบด้วยแอนติบอดีชนิดเดียวกันนี้ และรีเอเจนท์สำหรับตรวจวิเคราะห์โพรเรนินโดยใช้แอนติบอดีดังกล่าว

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1572743

Country of ref document: EP